Encompass Health (EHC) Stock Price

Encompass Health Price

NYSE·CLOSED
125.12
​
Market closed

Over the last 19 years Encompass Health grew revenue by 6.8% annually, reaching 5.94 B USD. Earnings per share have declined at 2.2% per year over the last 18 years. For Encompass Health, the net margin of 9.5% is broadly stable versus 10.3% a few years ago. At today's price the dividend yield works out to roughly 0.56%. The payout ratio is around 13% of earnings. The dividend has grown at 5.7% per year over the past 12 years. The consensus 12-month price target for Encompass Health is 151.00 USD, about 20.7% above where the stock trades today. Of 18 analysts, 17 rate the stock a buy — an overall Buy consensus.

Encompass Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Encompass Health business model & stock analysis

Encompass Health Corp is an American company that provides healthcare services for patients with complex medical needs. The company was founded in 1984 in Birmingham, Alabama and has since become a leading provider of rehabilitation services in the USA and Puerto Rico. Encompass Health's business model is based on providing acute care rehabilitation and nursing for patients suffering from severe injuries, illnesses, or other traumatic events. The company offers services such as physical, occupational, and speech therapy rehabilitation, medical nursing, and palliative care. Encompass Health is divided into four divisions: rehabilitation facilities, home health, hospice and palliative care, and a group purchasing organization. In each division, the company offers a wide range of products and services to meet the needs of patients and customers. Encompass Health has taken a pioneering role in introducing new technologies and treatment methods in the field of rehabilitation and nursing. The company continuously invests in developing innovative solutions to improve the health and well-being of its patients. Encompass Health employs approximately 42,000 employees in the USA and is headquartered in Birmingham, Alabama. It is listed on the New York Stock Exchange under the ticker symbol EHC. Overall, Encompass Health Corp is a leading provider of healthcare services and solutions in the USA, well-positioned to continue playing an important role in the industry in the future.

Frequently asked questions about Encompass Health

Encompass Health Corp operates as a leading integrated healthcare services provider. The company's business model primarily focuses on offering post-acute healthcare services and rehabilitation therapies. With a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, Encompass Health aims to provide high-quality, personalized care to patients recovering from illnesses, injuries, or surgeries. Through its interdisciplinary approach, advanced technologies, and clinical expertise, Encompass Health Corp strives to improve patients' health outcomes and enhance their overall quality of life.

Encompass Health Corp is primarily active in the healthcare industry.

Encompass Health Corp faces competition from various companies in the market. Some of its main competitors include Kindred Healthcare, Select Medical Holdings Corporation, and HealthSouth Corporation.

Encompass Health Corp, formerly known as HealthSouth Corporation, is a leading provider of integrated healthcare services in the United States. Founded in 1984, the company has a rich history and a strong background in rehabilitation and home health services. Encompass Health Corp offers a wide range of services, including inpatient rehabilitation, outpatient care, and home health services across various settings. With a commitment to delivering high-quality care and improving patients' lives, Encompass Health Corp has grown to become one of the largest post-acute healthcare providers in the country, serving thousands of patients annually. The company's dedication to innovation and excellence has earned it a solid reputation in the healthcare industry.

Encompass Health Corp has achieved several significant milestones over the years. Firstly, the company expanded its operations and became the leading provider of integrated post-acute healthcare services in the United States. Furthermore, they successfully rebranded their name from HealthSouth Corporation to Encompass Health Corp in 2018, showcasing their commitment to comprehensive and innovative care. Encompass Health Corp has consistently ranked among Fortune 500 companies and has received recognition for its quality patient care and clinical outcomes. Additionally, the company continues to grow its network of hospitals, home health agencies, and hospice centers, ensuring a broad range of services to meet patients' evolving needs.

Encompass Health Corp is primarily present in the United States.

Encompass Health Corp represents a strong emphasis on patient-centered care and providing high-quality, compassionate healthcare services. The company's values revolve around integrity, excellence, collaboration, and compassion. Encompass Health Corp is dedicated to delivering innovative healthcare solutions and improving the lives of patients through personalized care plans and advanced medical technologies. With a focus on positive patient outcomes, the company strives to continually enhance its services, expand its reach, and contribute positively to the communities it serves. Encompass Health Corp's corporate philosophy centers on delivering exceptional care with a commitment to clinical excellence, integrity, and respect for individuals.

Analysts currently set an average price target of 150.25 USD for the Encompass Health stock (median: 151.00 USD), implying +20.1 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Encompass Health stock: 17 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Encompass Health to generate revenue of 6.46 B USD and earnings per share of 6.12 USD.

Converted at the current exchange rate, the Encompass Health share trades at 111.54 EUR (125.12 USD).

The Encompass Health share (EHC) is listed on 2 stock exchanges, including: NYSE (EHC), Frankfurt (HSOA.F).

Encompass Health Corp is a leading provider of rehabilitation services in the United States. The company operates 140 hospitals, rehabilitation centers, and home health services in 39 states, serving millions of patients annually. The company's business model focuses on offering a comprehensive range of rehabilitation services, including hospital rehabilitation, in-patient rehabilitation, in-home healthcare, and long-term care. Encompass Health's services aim to restore patients' independence and mobility, improving their quality of life. The company offers a wide range of treatments, including therapy, rehabilitation, and nursing care, and utilizes modern technologies such as robots to assist patients. Collaboration with insurance companies and government agencies is an important part of Encompass Health's business model, enabling the company to provide its services and expand access to healthcare for a broader population. In addition, the company offers specialized rehabilitation programs for patients with brain injuries, spinal cord injuries, strokes, and other neurological disorders. Encompass Health also sells medical equipment and accessories and provides electronic patient documentation and billing systems to other healthcare facilities. The company's success is attributed to its focus on a crucial niche in the healthcare industry and the increasing demand for rehabilitation services due to an aging population and the need for support after accidents and illnesses. By utilizing modern technology to achieve medical advancements and providing value-based care, Encompass Health is able to offer high-quality services to patients while maintaining a profitable business model. In summary, Encompass Health's business model is centered around providing comprehensive and coordinated rehabilitation services to patients. The company's use of modern technology and partnerships with insurance companies and government agencies are key to its success. The company is well-positioned to meet the demands of the growing rehabilitation market and expand its market share.

The expected revenue of Encompass Health is 6.46 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Encompass Health is 624.61 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Encompass Health is currently 20.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Encompass Health stock.

The price-to-sales ratio (P/S) of Encompass Health is currently 1.98. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Encompass Health stock.

The Eulerpool Quality Score for Encompass Health is 8/10.

The ISIN of Encompass Health is US29261A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Encompass Health is A2H9HM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Encompass Health is EHC. The ticker symbol is used to trade Encompass Health shares on the stock exchange.

Fair ValueTerminal
117.61 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
141,314.29 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Sep 24, 1986
ISIN
US29261A1007
Cusip
29261A100
Sedol
BYX2YJ7
Market capitalization
12.79 B USDLarge Cap
52-Week Range
PEG
2.60
P/E ratio
P/Ee 2026
20.47
P/Ee 2027
18.74
P/Ee 2028
17.16
P/Ee 2029
14.82
P/Ee 2030
13.51
P/S
P/Se
1.98
EV/EBIT
12.92
P/B Ratio
5.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.43 %
Dividend
Dividend yield
0.56 %
Est. Dividend Yield
0.63 %
Payout Ratio
12.61 %
Dividend growth Ø5Y
-8.97 %
Dividend payments per year
4
Dividend paid since
13 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
30.00 %
Last updated Oct 20, 2026, 10:13 AM

Encompass Health Ticker

FRANKFURT · HSOA.FNEW YORK · EHC

Encompass Health FIGI

EHC:US · BBG000BGBRG2EHC:UA · BBG000BGBRX3EHC:UC · BBG000BGBSY0EHC:UN · BBG000BGBVK8EHC:UP · BBG000BGBVT9EHC:UB · BBG000BGBWP1EHC:UT · BBG000BGBX33EHC:UM · BBG000BGBXB4EHC:UX · BBG000BGC0G0EHC:UD · BBG000BGC2Y6EHC:UF · BBG000BGC5J6EHC:VY · BBG000BGC5X0